Premal H. Thaker

Also affiliated with Washington University in St. Louis, University of Missouri–St. Louis, Cancer Research Center, Woman's Cancer Foundation

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.006

Top 65%

0.208DataRank

Top 65%3 citations

Angeles Alvarez Secord, Steven G. Friedman, Erinn M. Hade, Carson Smitherman, Nikita Bisht +14 more

Papers

Driven by 40 papers — median percentile 35. Top paper: “Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response”.

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response

Clinical Oncology(2021)10.1016/j.clon.2021.01.010

N/A

1.2DataRank · unranked

13 citations

Farrokh Dehdashti, L. Stewart Massad, Premal H. Thaker, Matthew A. Powell, David G. Mutch +5 more

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005919

N/A

0.812DataRank · unranked

25 citations

Bradley J. Monk, Els Van Nieuwenhuysen, Kathleen N. Moore, Michel Fabbro, David M. O’Malley +16 more

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Journal of Clinical Oncology(2025)10.1200/jco-25-00112

N/A

0.722DataRank · unranked

36 citations

Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D’Hondt, Bradley J. Monk, Andrew R. Clamp +20 more

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.578

N/A

0.399DataRank · unranked

12 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Mark S. Reed, Melanie K Bergman +21 more

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.006

Top 65%

0.208DataRank

Top 65%3 citations

Angeles Alvarez Secord, Steven G. Friedman, Erinn M. Hade, Carson Smitherman, Nikita Bisht +14 more

Rural residence is related to shorter survival in epithelial ovarian cancer patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.07.035

N/A

0DataRank · unranked

29 citations

Edgardo Ramírez, Andrew Schrepf, Mark C. Valentine, Mary E. Charlton, M. Bridget Zimmerman +5 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors

Scientific Reports(2021)10.1038/s41598-021-89934-6

N/A

0DataRank · unranked

18 citations

Marlon A. McGill, Marina K Triplett, Anisha Tyagi, Premal H. Thaker, Laila Dahmoush +9 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

Chronic difficulties are associated with poorer psychosocial functioning in the first year post‐diagnosis in epithelial ovarian cancer patients

Psycho-Oncology(2021)10.1002/pon.5682

N/A

0DataRank · unranked

7 citations

George M. Slavich, Andrew Schrepf, Lauren Z. Davis, Premal H. Thaker, Michael J. Goodheart +4 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

Ovarian Tumor Mitochondria Exhibit Abnormal Phenotypes and Blunted Associations with Biobehavioral Factors

Research Square(2021)10.21203/rs.3.rs-246331/v1

N/A

0DataRank · unranked

0 citations

Marlon A. McGill, Marina K Triplett, Anisha Tyagi, Premal H. Thaker, Laila Dahmoush +9 more

Ovarian Tumor Mitochondria Exhibit Abnormal Phenotypes and Blunted Associations with Biobehavioral Factors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.26.432917

N/A

0DataRank · unranked

0 citations

Marlon A. McGill, Marina K Triplett, Anisha Tyagi, Premal H. Thaker, Laila Dahmoush +9 more

Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications

Current Oncology Reports(2022)10.1007/s11912-022-01221-3

N/A

0DataRank · unranked

18 citations

Alexander C. Cohen, Charles A. Leath, Elizabeth Evans, Ronald D. Alvarez, Premal H. Thaker +1 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.011

N/A

0DataRank · unranked

12 citations

Mary M. Mullen, Rehan Nizamuddin, Jonathan H. Stein, Lindsay M. Kuroki, Katherine C. Fuh +8 more

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy

Scientific Reports(2022)10.1038/s41598-022-19778-1

N/A

0DataRank · unranked

7 citations

Sitai Kou, Yixiao Lin, Andrea R. Hagemann, Ian S. Hagemann, Premal H. Thaker +7 more

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101060

N/A

0DataRank · unranked

3 citations

Sophia Lewis, Mark C. Valentine, M. Palisoul, Premal H. Thaker, Andrea R. Hagemann +6 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3335

N/A

0DataRank · unranked

65 citations

Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi +18 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients

Brain Behavior and Immunity(2023)10.1016/j.bbi.2023.12.014

N/A

0DataRank · unranked

11 citations

Rachel Telles, Brendan M. Whitney, Premal H. Thaker, George M. Slavich, Michael J. Goodheart +6 more

In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy

npj Precision Oncology(2023)10.1038/s41698-023-00454-0

N/A

0DataRank · unranked

8 citations

Sunil Badal, Meredith Spradlin, Michael F. Keating, Igor Pereira, Elaine Stur +19 more

Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic

Journal of Psychosocial Oncology(2023)10.1080/07347332.2023.2244474

N/A

0DataRank · unranked

4 citations

Sharaf Zia, Breanna Greteman, Premal H. Thaker, Frank J. Penedo, Mary E. Charlton +6 more

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O‐RADS risk assessment

Ultrasound in Obstetrics and Gynecology(2023)10.1002/uog.27452

N/A

0DataRank · unranked

3 citations

Hongbo Luo, William D. Middleton, Malak Itani, Ian S. Hagemann, Andrea R. Hagemann +8 more

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.021

N/A

0DataRank · unranked

4 citations

Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah F. DeLair, Sheila Segura +10 more

Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.027

N/A

0DataRank · unranked

20 citations

Danielle Enserro, Matthew S. Block, Steven Waggoner, Linda Duska, Andrea E. Wahner-Hendrickson +11 more

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005303

N/A

0DataRank · unranked

8 citations

Surbhi Grover, Yi Huang, Premal H. Thaker, Lindsay M. Kuroki, Matthew A. Powell +6 more

Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.024

N/A

0DataRank · unranked

2 citations

M. Bridget Zimmerman, Premal H. Thaker, George M. Slavich, Edgardo Ramírez, Sharaf Zia +5 more

Quality of life and survivorship in patients with low-grade ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.08.010

N/A

0DataRank · unranked

1 citations

Rachel Telles, Michael J. Goodheart, Laila Dahmoush, Ian S. Hagemann, Frank J. Penedo +6 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more

Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation

Cell Death and Disease(2020)10.1038/s41419-020-03055-y

N/A

0DataRank · unranked

84 citations

Megan M. Richters, Sangappa B. Chadchan, Tae Hoon Kim, Eric Tycksen, Obi L. Griffith +4 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094

N/A

0DataRank · unranked

0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

UNC Libraries(2020)10.17615/4pe6-bb70

N/A

0DataRank · unranked

2 citations

Kay J. Park, David G. Mutch, Shashikant B. Lele, Louise A. Brinton, Shamshad Ali +14 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms

Cancer Research(2021)10.1158/0008-5472.can-21-0684

N/A

0DataRank · unranked

55 citations

Premal H. Thaker, Susan K. Lutgendorf, Suzanne D. Conzen, Renée L. Flaherty, Melanie S. Flint +1 more

Premal H. Thaker

Indexed papers

Top data-sharing exemplar

Papers